Bridgewater Associates’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.65M Sell
47,780
-54,291
-53% -$3.91M 0.02% 492
2025
Q4
$6.52M Buy
+102,071
New +$6.29M 0.02% 458
2025
Q3
Sell
-9,779
Closed -$730K 1029
2025
Q2
$730K Sell
9,779
-120,926
-93% -$9.5M ﹤0.01% 494
2025
Q1
$11.5M Buy
130,705
+22,115
+20% +$2.09M 0.05% 238
2024
Q4
$9.92M Sell
108,590
-9,655
-8% -$990K 0.05% 258
2024
Q3
$13.2M Buy
118,245
+28,328
+32% +$2.83M 0.08% 222
2024
Q2
$8.81M Sell
89,917
-17,638
-16% -$1.75M 0.05% 267
2024
Q1
$10.8M Buy
107,555
+12,329
+13% +$1.08M 0.05% 244
2023
Q4
$8.55M Buy
95,226
+55,460
+139% +$4.42M 0.05% 267
2023
Q3
$3.05M Buy
39,766
+20,596
+107% +$1.71M 0.02% 436
2023
Q2
$1.6M Buy
+19,170
New +$1.56M 0.01% 503
2022
Q3
Sell
-122,413
Closed -$11M 912
2022
Q2
$11M Buy
122,413
+43,907
+56% +$4.55M 0.05% 311
2022
Q1
$8.8M Buy
+78,506
New +$9.2M 0.04% 327
2021
Q3
Sell
-39,780
Closed -$4.64M 716
2021
Q2
$4.64M Buy
+39,780
New +$4.78M 0.03% 344
2021
Q1
Sell
-12,232
Closed -$1.23M 498
2020
Q4
$1.23M Sell
12,232
-1,285
-10% -$119K 0.01% 360
2020
Q3
$1.06M Buy
13,517
+10,420
+336% +$785K 0.01% 336
2020
Q2
$216K Buy
+3,097
New +$195K ﹤0.01% 370
2020
Q1
Sell
-7,272
Closed -$576K 466
2019
Q4
$576K Sell
7,272
-139,649
-95% -$10.7M 0.01% 398
2019
Q3
$10.8M Sell
146,921
-151,260
-51% -$10.9M 0.1% 96
2019
Q2
$23.2M Sell
298,181
-301,843
-50% -$22.9M 0.18% 48
2019
Q1
$45.5M Sell
600,024
-24,531
-4% -$1.95M 0.28% 21
2018
Q4
$45.7M Buy
+624,555
New +$49.8M 0.42% 26
2017
Q3
Sell
-33,231
Closed -$2.79M 317
2017
Q2
$2.79M Buy
+33,231
New +$2.68M 0.03% 146
2016
Q4
Sell
-53,800
Closed -$3.64M 294
2016
Q3
$3.64M Sell
53,800
-85,000
-61% -$5.7M 0.04% 149
2016
Q2
$9.43M Buy
138,800
+73,283
+112% +$5.39M 0.12% 74
2016
Q1
$4.73M Sell
65,517
-72,052
-52% -$4.72M 0.06% 124
2015
Q4
$9.29M Sell
137,569
-243,469
-64% -$17M 0.12% 73
2015
Q3
$24.7M Buy
381,038
+335,500
+737% +$24.8M 0.33% 15
2015
Q2
$3.73M Sell
45,538
-181,000
-80% -$14M 0.03% 146
2015
Q1
$15.7M Sell
226,538
-75,248
-25% -$5.43M 0.12% 23
2014
Q4
$22.9M Buy
301,786
+243,659
+419% +$19.3M 0.18% 11
2014
Q3
$4.7M Buy
58,127
+12,000
+26% +$1M 0.04% 102
2014
Q2
$4.03M Buy
46,127
+34,140
+285% +$2.97M 0.03% 130
2014
Q1
$1.03M Sell
11,987
-36,400
-75% -$2.98M 0.01% 238
2013
Q4
$3.9M Sell
48,387
-5,900
-11% -$458K 0.03% 133
2013
Q3
$4.23M Buy
+54,287
New +$4.18M 0.04% 107

Other funds holding EMN

Bridgewater Associates's EMN Position: Q1 2026 in Review

Bridgewater Associates reduced its Eastman Chemical (EMN) stake by 53% in Q1 2026, selling an estimated $3.91M and leaving 47,780 shares worth $3.65M. The position accounts for 0.02% of the portfolio, ranked #492.

Bridgewater Associates first reported a position in EMN in Q3 2013 and has held it in 36 quarters since. The position peaked at $45.7M in Q4 2018. 634 funds tracked by Wall St. Rank hold EMN as of Q1 2026.

  • Bridgewater Associates held 47,780 shares of Eastman Chemical worth $3.65M as of Q1 2026.
  • Bridgewater Associates sold 54,291 Eastman Chemical shares in Q1 2026, an estimated $3.91M.
  • Eastman Chemical made up 0.02% of Bridgewater Associates's portfolio in Q1 2026, its #492 holding.
  • Bridgewater Associates first reported a position in Eastman Chemical in Q3 2013 and has held it in 36 quarters since.
  • Bridgewater Associates's Eastman Chemical position peaked at $45.7M in Q4 2018.
  • 634 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.